The present disclosure generally relates to systems and methods for providing a therapy to a patient. More particularly, the present disclosure relates to a catheter for mapping and ablating tissue within the heart of the patient including mapping electrodes deposited on an exterior surface of the ablation electrode.
Atrial fibrillation is a condition in the heart causing irregular heartbeats due to generation of abnormal electrical signals. Various treatment regimens may be followed for treating arrhythmias, such as anti-arrhythmic medications and catheter ablation.
Catheter ablation is a non-surgical, minimally invasive procedure that involves killing an abnormal heart muscle responsible for heart racing. This produces a small area of dead heart muscle called a lesion. In order to make lesions and thereby treat arrhythmia, abnormal heart muscles are first targeted and mapped, such as through a mapping technique. A catheter generally includes one or more mapping electrodes configured to carry out mapping functions and a tip ablation electrode disposed at the tip portion configured to carry out the ablation function. Mapping typically involves percutaneously introducing the catheter having one or more mapping electrodes into the patient, passing the catheter through a blood vessel (e.g., the femoral vein or artery) and into an endocardial site (e.g., the atrium or ventricle of the heart) to map bioelectrical signals arising from the myocardial tissues and thereby, recognize the tissue that is the source of the arrhythmia. The tip of the ablation catheter including the tip ablation electrode can then deliver energy to the abnormal heart muscle, which disables it.
Disclosed herein are embodiments of an ablation electrode including one or more mapping electrodes deposited on an exterior surface thereof at a distal end of a map and ablate catheter, as well map and ablate catheters including such deposited mapping electrodes.
In Example 1, a system for performing mapping and ablation functions includes a catheter sized and shaped for vascular access. The catheter includes an elongate body extending between a proximal end and a distal end. The catheter further includes a tip section positioned at the distal end of the body such that the tip section includes a proximal portion and a distal portion. The system also includes one or more electrode structures on an exterior surface of the tip section such that the one or more electrode structures each includes a mapping electrode at the distal portion of the tip section and a contact pad electrically coupled to the mapping electrode.
In Example 2, the system according to Example 1, wherein the tip section includes an ablation electrode configured to deliver radio frequency (RF) energy for an RF ablation procedure, and wherein the one or more electrode structures are deposited on an exterior surface of the ablation electrode.
In Example 3, the system according to either Example 1 or Example 2, wherein the one or more electrode structures further includes an insulative base layer between each of the one or more electrode structures and the ablation electrode.
In Example 4, the system according to any of Examples 1-3, wherein the catheter includes at least one inner fluid lumen, wherein the ablation electrode includes an exterior wall that defines an open interior region within the ablation electrode, and wherein the catheter system further includes a thermal mass within the open interior region and a cooling chamber in fluid communication with the at least one inner fluid lumen of the elongate body and positioned proximally to the thermal mass.
In Example 5, the system according to any of Examples 1-4, wherein the ablation electrode includes an exterior wall that defines an open interior region within the ablation electrode, wherein the exterior wall includes irrigation ports, and wherein the irrigation ports are in fluid communication with the open interior region to allow fluid to flow from the open interior region through the irrigation ports.
In Example 6, the system according to any of Examples 1-5, wherein the tip section includes a flexible balloon removably coupled to the distal end of the catheter.
In Example 7, the system according to any of Examples 1-6, and further comprising one or more mapping ring electrodes disposed on the body proximal to the one or more electrode structures.
In Example 8, the system the system according to any of Examples 1-7, wherein each of the one or more electrode structures further includes a conductive trace between the contact pad and mapping electrode, and an insulative coating layer over the conductive trace.
In Example 9, the system according to Examples 8, wherein the conductive trace has an impedance of less than 100 ohms.
In Example 10, the system according to any of Examples 1-9, wherein the one or more electrode structures are formed via physical vapor deposition.
In Example 11, a system for performing mapping and ablation functions includes a catheter sized and shaped for vascular access. The catheter includes an elongate body extending between a proximal end and a distal end and having at least one inner fluid lumen. The system further includes an ablation electrode coupled to the distal end of the catheter body, wherein the ablation electrode is configured to deliver radio frequency (RF) energy for an RF ablation procedure. The ablation electrode also includes an exterior wall that defines an open interior region within the ablation electrode. The system further includes a thermal mass within the open interior region and a cooling chamber in fluid communication with the at least one inner fluid lumen of the elongate body and positioned proximally to the thermal mass. The system further includes one or more insulative base layers on an exterior surface of the ablation electrode and one or more mapping electrodes each disposed on one of the one or more insulative base layers such that each mapping electrode can be proximate to a distal end of the ablation electrode.
In Example 12 the system according to Example 11, and further comprising one or more contact pads at a proximal end of the ablation electrode, wherein each contact pad is electrically coupled to one of the one or more mapping electrodes.
In Example 13, the system according to either Example 11 or Example 12, wherein each contact pad is connected to one of the one or more mapping electrodes via a conductive trace.
In Example 14, the system according to Example 13, and further comprising an insulative coating layer over the conductive trace.
In Example 15, the system according to any of Examples 11-14, and further comprising one or more mapping ring electrodes disposed on the body proximal to the one or more electrode structures.
In Example 16, the system according to any of Examples 11-15, wherein the mapping electrodes are formed via physical vapor deposition.
In Example 17, a system for performing mapping and ablation functions includes a radio frequency (RF) generator, a fluid reservoir and pump, a mapping signal processor, and a catheter sized and shaped for vascular access. The catheter includes an elongate body extending between a proximal end and a distal end having at least one inner fluid lumen in fluid communication with the fluid reservoir and pump. The system further includes an ablation electrode coupled to the distal end of the catheter body, and operably connected to the RF generator. The ablation electrode includes an exterior wall that defines an open interior region within the ablation electrode. The system further includes one or more insulative base layers on an exterior surface of the ablation electrode and one or more mapping electrodes operably connected to the mapping signal processor such that each mapping electrode can be disposed on one of the one or more insulative base layers. Each mapping electrode can be proximate to a distal end of the ablation electrode.
In Example 18 the system according to Example 17, and further comprising a thermal mass within the open interior region and a cooling chamber in fluid communication with the at least one inner fluid lumen of the elongate body and positioned proximally to the thermal mass.
In Example 19 the system according to either Example 17 or Example 18, and further comprising one or more contact pads at a proximal end of the ablation electrode electrically connected to the mapping signal processor, wherein each contact pad is electrically coupled to one of the one or more mapping electrodes via a conductive trace.
In Example 20, the system according to Example 19, and further comprising an insulative coating layer over each conductive trace.
While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.
The catheter 102 can include an elongate body 114 having a proximal end 116 and a distal end 118. The body houses electrical conductors/cable assembly (e.g., wires) 120 for transmitting sensed signals and/or ablation energy. The elongate body 114 is preferably about 1.67 mm to 3 mm in diameter, and between 800 mm to 1500 mm in length. The elongate body 114 preferably has a circular cross-sectional geometry. However, other cross-sectional shapes, such as elliptical, rectangular, triangular, and various other shapes, can be provided. In some embodiments, the elongate body 114 can be preformed of an inert, resilient plastic material that retains its shape and does not soften significantly at body temperature; for example, Pebax®, polyethylene, or Hytrel®) (polyester). Alternatively, the elongate body 114 can be made of a variety of materials, including, but not limited to, metals and polymers. The elongate body 114 is preferably flexible so that it is capable of winding through a tortuous path that leads to a target site, i.e., an area within the heart. Alternatively, the elongate body 114 can be semi-rigid, i.e., by being made of a stiff material, or by being reinforced with a coating or coil, to limit the amount of flexing.
In some embodiments, the movement of the distal end 118 of the elongate body 114 (such as to wind through the tortuous path that leads to a target site) can be controlled by a control mechanism 122 included within the handle 120. The system 100 can include an articulating section of the elongate body 114 (e.g., near the distal end 118) that is controlled via the control mechanism 122. In some embodiments, the distal end 118 of the elongate body 114 can be deflected or bent. The articulation section of the body can facilitate insertion of the catheter 102 through a body lumen (e.g., vasculature) and/or placement of electrodes at a target tissue location. The articulation section can provide one or more degrees of freedom and permit up/down and/or left/right articulation. One skilled in the art will understand that the control mechanism 122 and the articulating section of the catheter 102 can include a variety of features associated with conventional articulating catheters.
The distal end 104 of the catheter 102 includes a tip section 124 positioned at the distal end 118 of the elongate body 114. The tip section 124 includes a proximal portion 134 and a distal portion 136. In some embodiments, the tip section 124 is formed from a conductive material. For example, in some embodiments the tip section 124 is comprised of a platinum-iridium alloy. In one exemplary embodiment, the platinum iridium top section 124 comprises an alloy with approximately 90% platinum and 10% iridium. This conductive material is used to conduct radio frequency (RF) energy used to form lesions during the ablation procedure. The ablation electrode 126 can have any suitable length, for example, in the range between 4 mm and 10 mm. The ablation electrode 126 can be composed of a solid, electrically conductive material, such as platinum, gold, or stainless steel. The ablation electrode 126 can be configured to deliver ablation energy to the myocardial tissues that are the source of arrhythmia, thereby destroying them or a portion thereof through heat. In an embodiment, the ablation electrode 126 can be electrically coupled to an RF generator, which will be discussed in further detail with regards to
The system 100 includes one or more electrode structures 142 on an exterior surface 130 of the tip section 124. The electrode structures 142 each include a mapping electrode 132 at the distal portion 136 of the tip section 124. The mapping electrode 132 is deposited on the tissue ablation electrode 126, and in particular, is deposited on an exterior surface 130 of the ablation electrode 126. This can allow the localized intracardial electrical activity to be measured in real time at the point of RF energy delivery from the ablation electrode 126 thereby allowing the physician to ascertain lesion formation by measuring the electrical activity of the tissue in contact with the tip ablation electrode 126 (e.g., the lack of electrical activity indicates ablated tissue, whereas the presence of electrical activity indicates live tissue). In some embodiments, the mapping electrodes 132 are deposited on the exterior surface 130 of the ablation electrode 126. In some embodiments, the one or more electrode structures 142 are deposited via physical vapor deposition (PVD). The physical vapor deposition may be used for the deposition of the electrodes formed of a metal. In alternative embodiments, other deposition techniques may be used for electrode deposition on the exterior surface 130 of the ablation electrode 126, such as sputtering.
In some embodiments, the electrode structures 142 each includes a contact pad that is electrically coupled to the mapping electrode 132. The contact pad can be configured to provide connection of the mapping electrode 132 with the cable assembly 120, thereby allowing the mapping electrode 132 to form electrical connection with the electrical circuitry of the catheter 102. In some embodiments, the mapping electrode 132 are electrically coupled to a mapping signal processor, which will be discussed in further detail with regards to
The system 100 may also include one or more mapping ring electrodes 140. The mapping ring electrodes 140 can be configured to map the bioelectrical signals arising from the myocardial tissues and thereby recognize the tissues that are the source of arrhythmia. The mapping ring electrodes 140 can include a distal mapping ring electrode 140a, a medial mapping ring electrode 140b, and a proximal mapping ring electrode 140c. The mapping ring electrodes 140a, 140b, and 140c as well as the ablation electrode 126 are capable of forming a bipolar mapping electrode pairs. For example, the ablation electrode 126 and distal mapping ring electrode 140a can be configured as a first bipolar mapping electrode pair, the distal mapping ring electrode 140a and the medial mapping ring electrode 140b can be configured as a second bipolar mapping electrode pair, the medial mapping ring electrode 140b and the proximal mapping ring electrode 140c can be configured as a third bipolar mapping electrode pair, or any combination thereof. Like the mapping electrodes 132, the mapping ring electrodes 140a-140c are also electrically coupled to the mapping signal processor via the signal wires 138 to map electrical events in the myocardial tissues.
Although the radio frequency (RF) generator 202, the fluid reservoir and the pump 204, and the mapping signal processor 206 are shown as discrete components, they can alternatively be incorporated into a single integrated device.
In some embodiments, the ablation electrode 126 coupled to the distal end 118 of the catheter body 114 can be operably connected to the RF generator 202. The RF generator 202 can be used to generate the energy for the ablation procedure. The RF generator 202 includes a source 208 for the RF energy and a controller 210 for controlling the timing and the level of the RF energy delivered through the tip 204. The illustrated system 100 also includes the fluid reservoir and pump 204 for pumping cooling fluid, such as a saline, through an inner fluid lumen of the catheter 102 (which will be discussed in greater detailed below) to the tip portion 124.
The mapping signal processor 206 can be operably coupled to the one or more electrodes similar to the mapping electrode 132. The mapping signal processor 206 can be configured to detect, process, and record electrical signals within the heart via the one or more electrodes of the catheter 102. Based on the electrical signals sensed by the one or more electrodes, the physician can identify the specific target tissue sites within the heart, and ensure that the arrhythmia causing substrates have been electrically isolated by the ablative treatment. Based on the detected electrical signals, the mapping signal processor 206 outputs electrocardiograms (ECGs) to a display (not shown), which can be analyzed by the physician to determine the existence and/or location of arrhythmia substrates within the heart and/or determine the location of the catheter 102 within the heart. In some embodiments, the mapping signal processor 206 can generate an isochronal map of the detected electrical activity and output the map to the display for analysis by the physician.
The mapping electrodes 132 can be small, independent diagnostic sensing electrodes deposited on the exterior surface 130 of the tip 304 of the RF ablation catheter 102. Each mapping electrode 132 can be composed of an electrically conductive material, such as platinum, gold, or stainless steel. In some embodiments, the mapping electrodes 132 are comprised of a silver/silver chloride to maximize the coupling between the mapping electrode 132 and blood, thereby optimizing signal fidelity. In some embodiments, the electrode structures 142 are formed via physical vapor deposition (PVD) or other suitable methods for deposing the electrodes onto the exterior surface 130.
The mapping electrodes 132 can be disposed on the ablation electrode 126 in any one of a variety of different patterns. In an example, as shown in
In some embodiments, each of the electrode structures 142 further includes a conductive trace 306 electrically coupled to the mapping electrode 132 and a contact pad 308 electrically connected to the conductive trace 306. In some embodiments, the contact pads 308 are disposed at a proximal portion of the tip 304. The contact pad 308 may be configured for electrical connection to a diagnostic device such as the mapping processor 206. In an embodiment, the conductive trace 306 can be offset either along the longitudinal or lateral axes of the catheter system 102 from the mapping electrode 132 so long as some portion of the conductive trace 306 remains in contact with the mapping electrode 132. Accordingly, the lateral and longitudinal cross-sections of both the mapping electrode 132 and the conductive trace 306 may vary similar to the variation in the depth or thickness of the conductive trace 306 and mapping electrode 132. In some embodiments, the conductive traces 306 have an impedance of less than 100 ohms.
In some embodiments, the catheter 102 includes a plurality of internal conductors each coupled to one of the contact pads 308. Thus, each of the mapping electrodes 132 can be electrically connected to other semiconductor devices, electronic components on the substrate, or components that are external to the catheter 102 such as the mapping processor.
In some embodiments, the electrodes 126, 132, and/or 140, the conductive trace 306, and contact pad 308 can be made from the same conductive materials. In some embodiments, the electrodes 126, 132, and/or 140, conductive trace 306, and contact pad 308 can be made of different conductive materials. For example, the contact pads 308 can be formed of a material such as gold (Au), platinum (Pt), palladium (Pd), ruthenium (Ru), rhodium (Rh), iridium (Ir), carbon (C), or other material that resists oxidation. The conductive traces 306 can be formed of any suitable conductive material, such as Au, Pt, or copper (Cu). The electrodes 126, 132, and/or 140, conductive trace 306, or contact pad 308 may be comprised of any suitable material including, for example, Pt, Au, Pd, Ru, Rh, Ir, silver (Ag), C, and their alloys or oxides. Conducting polymers, such as polypyrrole (PPy), polyaniline (PANi), polythiophene, poly(3,4-ethylenedioxythiophene) (PEDOT) or their derivatives may also be employed for the conductive elements of the catheter 102.
The electrode structures 142 may further include a multi-layer dielectric material 310 such that the multi-layer dielectric material 310 includes an insulative base layer 312 and/or an insulative coating layer 314. The multi-layer dielectric material 310 acts as a dielectric barrier between the ablation electrode 126 and the electrode structures 142 resisting the conductance of the RF energy from the ablation electrode 126 to the electrode structures 142. For this purpose, the system 100 includes the insulative base layers 312 between each of the one or more electrode structures 142 and the ablation electrode 126.
The insulative base layer 312 can be composed of a suitable electrically and thermally insulative material, such as a high temperature thermoset plastic with high dielectric properties, e.g., polyimide or plastics from the phenolic group, such as Bakelite® or Ultem® plastics. The electrically insulative material of the insulative base layer 312 makes the mapping electrode 132 electrically insulated from the ablation electrode 126, and thus, from each other, so that each of the mapping electrode 132 can provide independent mapping channels. The thermal insulative material of the insulative base layer 312 makes the mapping electrode 132 thermally insulated from the ablation electrode 126 to prevent saturation of the mapping channels that would otherwise cause interference from the heat generated during a radio frequency (RF) ablation procedure. The insulative base layer 310 can be formed on the exterior surface 130 of the ablation electrode 126 in a manner such that the mapping electrodes 132 can be each disposed on the insulative base layers 312 such that each of the mapping electrode 132 can be proximate to the ablation electrode 126. The insulative base layer 312 can be further coated with an insulative coating layer 314 such that the insulative coating layer 314 is provided over each of the conductive trace 306. The insulative coating layer 314 electrically isolates the conductive trace from surrounding structures.
In some embodiments, the tip section 124 includes a thermal mass 404. The thermal mass 404 comprises a material having a high thermal conductivity. A temperature sensor 406 can be positioned at least partially within the thermal mass 404. In an embodiment, the thermal mass 404 substantially extends across the full width of the tip 124.
The tip section 124 further includes a cooling chamber 408 in fluid communication with the inner fluid lumens 402 of the elongate body 114 and positioned proximally to the thermal mass 404. The cooling chamber 408 substantially extends across an entire width of the tip 124 between the exterior walls similar to the exterior wall 130 of the tip 304. The cooling chamber 408 can be defined in the form of a cavity near the proximate end of the tip 124 that is bounded at its distal end 412 by the thermal mass 404 and is bounded at its proximal end 414 by a portion of the tip section 124 and/or by a portion of the elongate catheter body 114.
In the illustrated embodiment, the cooling chamber 408 is positioned proximal to at least a portion of the thermal mass 404 and/or adjacent to the proximal portion 110 of the tip section 124. As ablation energy moves through the tip section 124, areas of increased current density can develop and result in localized hotspots. The system 100, described herein, can reduce the effect of proximal hotspots through the use of the cooling chamber 408 in fluid communication with the fluid lumen 402 of the elongate body 114. As shown in
The tip section 124 includes one or more insulative base layers 416 on the exterior surface 130 of the ablation electrode 126 and one or more mapping electrodes similar to the mapping electrode 132 each disposed on one of insulative base layers 416. The electrically insulative material of the insulative base layer 416 makes the mapping electrode 132 electrically insulated from the ablation electrode 126 and from each other so that each of the mapping electrodes 132 can provide independent mapping channels.
Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the above described features.
This application claims the benefit of Provisional Application No. 61/702,626, filed Sep. 18, 2012, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4732149 | Sutter | Mar 1988 | A |
4763660 | Kroll et al. | Aug 1988 | A |
5217460 | Knoepfler | Jun 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5254088 | Lundquist et al. | Oct 1993 | A |
5318589 | Lichtman | Jun 1994 | A |
5324284 | Imran | Jun 1994 | A |
5331966 | Bennett et al. | Jul 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5341807 | Nardella | Aug 1994 | A |
5383874 | Jackson et al. | Jan 1995 | A |
5385146 | Goldreyer | Jan 1995 | A |
5391199 | Ben-Haim | Feb 1995 | A |
5398683 | Edwards et al. | Mar 1995 | A |
5423811 | Imran et al. | Jun 1995 | A |
5447529 | Marchlinski et al. | Sep 1995 | A |
5462521 | Brucker et al. | Oct 1995 | A |
5482054 | Slater et al. | Jan 1996 | A |
5500012 | Brucker et al. | Mar 1996 | A |
5573535 | Viklund | Nov 1996 | A |
5579764 | Goldreyer | Dec 1996 | A |
5582609 | Swanson et al. | Dec 1996 | A |
5647870 | Kordis et al. | Jul 1997 | A |
5718701 | Shai et al. | Feb 1998 | A |
5722402 | Swanson et al. | Mar 1998 | A |
5800482 | Pomeranz et al. | Sep 1998 | A |
5820568 | Willis | Oct 1998 | A |
5830213 | Panescu et al. | Nov 1998 | A |
5836990 | Li | Nov 1998 | A |
5868735 | Lafontaine | Feb 1999 | A |
5871483 | Jackson et al. | Feb 1999 | A |
5913856 | Chia et al. | Jun 1999 | A |
5916213 | Haissaguerre et al. | Jun 1999 | A |
6027500 | Buckles et al. | Feb 2000 | A |
6050994 | Sherman | Apr 2000 | A |
6059778 | Sherman | May 2000 | A |
6064905 | Webster, Jr. et al. | May 2000 | A |
6070094 | Swanson et al. | May 2000 | A |
6083222 | Klein et al. | Jul 2000 | A |
6099524 | Lipson et al. | Aug 2000 | A |
6116027 | Smith et al. | Sep 2000 | A |
6120476 | Fung et al. | Sep 2000 | A |
6171305 | Sherman | Jan 2001 | B1 |
6200314 | Sherman | Mar 2001 | B1 |
6216027 | Willis et al. | Apr 2001 | B1 |
6233491 | Kordis et al. | May 2001 | B1 |
6270493 | Lalonde et al. | Aug 2001 | B1 |
6290697 | Tu et al. | Sep 2001 | B1 |
6400981 | Govari | Jun 2002 | B1 |
6475213 | Whayne et al. | Nov 2002 | B1 |
6488678 | Sherman | Dec 2002 | B2 |
6491710 | Satake | Dec 2002 | B2 |
6508803 | Horikawa et al. | Jan 2003 | B1 |
6517533 | Swaminathan | Feb 2003 | B1 |
6517534 | McGovern et al. | Feb 2003 | B1 |
6537271 | Murray et al. | Mar 2003 | B1 |
6547788 | Maguire et al. | Apr 2003 | B1 |
6575966 | Lane et al. | Jun 2003 | B2 |
6579278 | Bencini | Jun 2003 | B1 |
6602242 | Fung et al. | Aug 2003 | B1 |
6640120 | Swanson et al. | Oct 2003 | B1 |
6647281 | Morency | Nov 2003 | B2 |
6656174 | Hegde et al. | Dec 2003 | B1 |
6666862 | Jain et al. | Dec 2003 | B2 |
6719756 | Muntermann | Apr 2004 | B1 |
6735465 | Panescu | May 2004 | B2 |
6796979 | Lentz | Sep 2004 | B2 |
6796980 | Hall | Sep 2004 | B2 |
6811550 | Holland et al. | Nov 2004 | B2 |
6837884 | Woloszko | Jan 2005 | B2 |
6845264 | Skladnev et al. | Jan 2005 | B1 |
6917834 | Koblish et al. | Jul 2005 | B2 |
6922579 | Taimisto et al. | Jul 2005 | B2 |
6932811 | Hooven et al. | Aug 2005 | B2 |
6950689 | Willis et al. | Sep 2005 | B1 |
6952615 | Satake | Oct 2005 | B2 |
7047068 | Haissaguerre | May 2006 | B2 |
7097643 | Cornelius et al. | Aug 2006 | B2 |
7112198 | Satake | Sep 2006 | B2 |
7247155 | Hoey et al. | Jul 2007 | B2 |
7347857 | Anderson et al. | Mar 2008 | B2 |
7438714 | Phan | Oct 2008 | B2 |
7519410 | Taimisto et al. | Apr 2009 | B2 |
7569052 | Phan et al. | Aug 2009 | B2 |
7736362 | Eberl et al. | Jun 2010 | B2 |
7740629 | Anderson et al. | Jun 2010 | B2 |
7799025 | Wellman | Sep 2010 | B2 |
7819863 | Eggers et al. | Oct 2010 | B2 |
8128617 | Bencini et al. | Mar 2012 | B2 |
8414579 | Kim et al. | Apr 2013 | B2 |
8579889 | Bencini | Nov 2013 | B2 |
8657814 | Werneth et al. | Feb 2014 | B2 |
8740900 | Kim et al. | Jun 2014 | B2 |
8894643 | Watson et al. | Nov 2014 | B2 |
9125668 | Subramaniam et al. | Sep 2015 | B2 |
9211156 | Kim et al. | Dec 2015 | B2 |
20010029371 | Kordis | Oct 2001 | A1 |
20020087208 | Koblish et al. | Jul 2002 | A1 |
20030088240 | Saadat | May 2003 | A1 |
20040082860 | Haissaguerre | Apr 2004 | A1 |
20040092806 | Sagon et al. | May 2004 | A1 |
20040116793 | Taimisto et al. | Jun 2004 | A1 |
20040215186 | Cornelius et al. | Oct 2004 | A1 |
20050059862 | Phan | Mar 2005 | A1 |
20050059962 | Phan et al. | Mar 2005 | A1 |
20050059963 | Phan et al. | Mar 2005 | A1 |
20050059965 | Eberl et al. | Mar 2005 | A1 |
20050065506 | Phan | Mar 2005 | A1 |
20050065508 | Johnson et al. | Mar 2005 | A1 |
20050070894 | McClurken | Mar 2005 | A1 |
20060089634 | Anderson et al. | Apr 2006 | A1 |
20060161146 | Cornelius et al. | Jul 2006 | A1 |
20060247607 | Cornelius et al. | Nov 2006 | A1 |
20060253116 | Avitall et al. | Nov 2006 | A1 |
20070049925 | Phan et al. | Mar 2007 | A1 |
20070270794 | Anderson et al. | Nov 2007 | A1 |
20080015568 | Paul et al. | Jan 2008 | A1 |
20080058836 | Moll et al. | Mar 2008 | A1 |
20080086073 | McDaniel | Apr 2008 | A1 |
20080140065 | Rioux et al. | Jun 2008 | A1 |
20080161705 | Podmore et al. | Jul 2008 | A1 |
20080161795 | Wang et al. | Jul 2008 | A1 |
20080195089 | Thiagalingam et al. | Aug 2008 | A1 |
20080243214 | Koblish | Oct 2008 | A1 |
20080281322 | Sherman et al. | Nov 2008 | A1 |
20080300454 | Goto | Dec 2008 | A1 |
20080312713 | Wilfley et al. | Dec 2008 | A1 |
20090048591 | Ibrahim et al. | Feb 2009 | A1 |
20090062790 | Malchano et al. | Mar 2009 | A1 |
20090062795 | Vakharia et al. | Mar 2009 | A1 |
20090093810 | Subramaniam et al. | Apr 2009 | A1 |
20090093811 | Koblish et al. | Apr 2009 | A1 |
20090131932 | Vakharia et al. | May 2009 | A1 |
20090163904 | Miller et al. | Jun 2009 | A1 |
20090182316 | Bencini | Jul 2009 | A1 |
20090240247 | Rioux et al. | Sep 2009 | A1 |
20090259274 | Simon et al. | Oct 2009 | A1 |
20090287202 | Ingle et al. | Nov 2009 | A1 |
20090299355 | Bencini et al. | Dec 2009 | A1 |
20100010487 | Phan et al. | Jan 2010 | A1 |
20100094274 | Narayan et al. | Apr 2010 | A1 |
20100106155 | Anderson et al. | Apr 2010 | A1 |
20100145221 | Brunnett et al. | Jun 2010 | A1 |
20100152728 | Park et al. | Jun 2010 | A1 |
20100168557 | Deno et al. | Jul 2010 | A1 |
20100168831 | Korivi et al. | Jul 2010 | A1 |
20100331658 | Kim et al. | Dec 2010 | A1 |
20110028820 | Lau et al. | Feb 2011 | A1 |
20110112569 | Friedman et al. | May 2011 | A1 |
20110125143 | Gross et al. | May 2011 | A1 |
20120101398 | Ramanathan et al. | Apr 2012 | A1 |
20120330304 | Vegesna et al. | Dec 2012 | A1 |
20130172715 | Just et al. | Jul 2013 | A1 |
20130190747 | Koblish et al. | Jul 2013 | A1 |
20130274582 | Afonso et al. | Oct 2013 | A1 |
20140012251 | Himmelstein et al. | Jan 2014 | A1 |
20140058375 | Koblish | Feb 2014 | A1 |
20140073893 | Bencini | Mar 2014 | A1 |
20140081112 | Kim et al. | Mar 2014 | A1 |
20140107453 | Maskara et al. | Apr 2014 | A1 |
20140107636 | Bencini | Apr 2014 | A1 |
20150011995 | Avitall et al. | Jan 2015 | A1 |
20150133914 | Koblish | May 2015 | A1 |
20150265341 | Koblish | Sep 2015 | A1 |
20150265348 | Avitall et al. | Sep 2015 | A1 |
20150342672 | Bencini et al. | Dec 2015 | A1 |
20150374436 | Subramaniam et al. | Dec 2015 | A1 |
Number | Date | Country |
---|---|---|
2682055 | Oct 2008 | CA |
1455655 | Nov 2003 | CN |
104640513 | May 2015 | CN |
1343426 | Sep 2003 | EP |
1343427 | Sep 2003 | EP |
1502542 | Feb 2005 | EP |
1547537 | Jun 2005 | EP |
0985423 | Apr 2006 | EP |
2136702 | Jul 2015 | EP |
200083918 | Mar 2000 | JP |
2009518150 | May 2009 | JP |
2010522623 | Jul 2010 | JP |
5336465 | Nov 2013 | JP |
2014012174 | Jan 2014 | JP |
20100021401 | Feb 2010 | KR |
101490374 | Feb 2015 | KR |
WO9221278 | Dec 1992 | WO |
WO9413358 | Jun 1994 | WO |
WO9725916 | Jul 1997 | WO |
WO9725917 | Jul 1997 | WO |
WO9736541 | Oct 1997 | WO |
WO9858681 | Dec 1998 | WO |
WO9927862 | Jun 1999 | WO |
WO0029062 | May 2000 | WO |
WO2007079278 | Jul 2001 | WO |
WO0158372 | Aug 2001 | WO |
WO0164145 | Sep 2001 | WO |
WO0205868 | Jan 2002 | WO |
WO0209599 | Feb 2002 | WO |
WO0219934 | Mar 2002 | WO |
WO0247569 | Jun 2002 | WO |
WO02102234 | Dec 2002 | WO |
WO03039338 | May 2003 | WO |
2010054409 | May 2010 | WO |
WO2010056771 | May 2010 | WO |
2012161880 | Nov 2012 | WO |
WO2008118992 | Jan 2014 | WO |
2014072879 | May 2014 | WO |
2015143061 | Sep 2015 | WO |
2015183635 | Dec 2015 | WO |
Entry |
---|
Goldberg, S. Nahum et al., “Variables Affecting Proper System Grounding for Radiofrequency Ablation in an Animal Model”, JVIR, vol. 11, No. 8, Sep. 2000, pp. 1069-1075. |
International Search Report and Written Opinion issued in PCT/US2008/058324, dated Aug. 18, 2008, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2012/055309, mailed Nov. 19, 2012, 13 pages. |
Machi MD, Junji, “Prevention of Dispersive Pad Skin Burns During RFA by a Simple Method”, Editorial Comment, Surg Laparosc Endosc Percutan Tech, vol. 13, No. 6, Dec. 2003, pp. 372-373. |
Neufeld, Gordon R. et al., “Electrical Impedance Properties of the Body and the Problem of Alternate-site Burns During Electrosurgery”, Medical Instrumentation, vol. 19, No. 2, Mar.-Apr. 1985, pp. 83-87. |
Partial International Search Report issued in PCT/US2012/0551545, mailed Dec. 20, 2012, 7 pages. |
Steinke, Karin et al., “Dispersive Pad Site burns With Modern Radiofrequency Ablation Equipment”, Surg Laparosc Endosc Percutan Tech, vol. 13, No. 6, Dec. 2003, pp. 366-371. |
International Preliminary Examination Report issued in PCT/US2013/060183, completed Mar. 24, 2015, 6 pages. |
International Preliminary Report on Patentability issued in PCT/US2013/056211, completed Feb. 24, 2015, 5 pages. |
International Preliminary Report on Patentability issued in PCT/US2013;060194, mailed Mar. 24, 2015, 6 pages. |
International Search Report and Written Opinion issued in PCT/US2013/060194, mailed Jan. 29, 2014, 10 pages. |
International Search Report and Written Opinion issued in PCT/US2013/056211, mailed Jan. 20, 2014. |
International Search Report and Written Opinion issued in PCT/US2013/060183, mailed Jan. 27, 2014, 10 pages. |
International Search Report and Written Opinion issued in PCT/US2013/060194, mailed Jan. 29, 2014. |
Haverkamp, W., et. al. Coagulation of Ventricular Myocardium Using Radiofrequency Alternating Current: Bio-Physical Aspects and Experimental Findings. PACE, 12:187-195, Jan. 1989, Part II. |
International Preliminary Report on Patentability issued in PCT/US2008/058324, mailed Sep. 29, 2009, 9 pages. |
International Search Report and Written Opinion issued in PCT/US2013/021013, mailed Apr. 5, 2013, 14 pages. |
International Search Report and Written Opinion issued in PCT/US2015/021300, mailed Jun. 9, 2015, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2015/055173, mailed Jan. 18, 2016, 11 pages. |
International Search Report and Written Opinion issued in PCT/US2015/057242, mailed Jan. 15, 2016, 11 pages. |
International Search Report and Written Opinion issued in PCTUS2015/031591, mailed Aug. 17, 2015, 11 pages. |
Piorkowski, Christopher et al., “First in Human Validation of Impedance-Based Catheter Tip-to-Tissue Contact Assessment in the Left Atrium”, Journal of Cardiovascular Electrophysiology, vol. 20, No. 12, Dec. 1, 2009, pp. 1366-1373. |
Pires, L. A., et. al. Temperature-guided Radiofrequency Catheter Ablation of Closed-Chest Ventricular Myocardium with a Novel Thermistor-Tipped Catheter. American Heart Journal, 127(6):1614-1618, Jun. 1994. |
Price, Adam et al., “Novel Ablation Catheter Technology that Improves Mapping Resolution and Monitoring of Lesion Maturation”, The Journal of Innovations in Cardiac Rhythm Management, vol. 3, 2002, pp. 599-609. |
Price, Adam et al., “PO3-39 Pin Electrodes Improve Resolution: Enhanced Monitoring of Radiofrequency Lesions in the Voltage and Frequency Domains”, Heart Rhythm 2010, 31st Annual Scientific Sessions, May 12-15 in Denver Colorado. |
Ring, E. R., et. al. Catheter Ablation of the Ventricular Septum with Radiofrequency Energy. American Heart Journal, 117(6):1233-1240, Jun. 1989. |
Zachary, J.M. et al., “PO4-86 Pin Electrodes Provide Enhanced Resolution Enabling Titration of Radiofrequency Duration to Lesion Maturation”, Heart Rhythm 2011, 32 Annual Scientific Sessions, May 4-7, San Francisco, CA. |
Number | Date | Country | |
---|---|---|---|
20140081111 A1 | Mar 2014 | US |
Number | Date | Country | |
---|---|---|---|
61702626 | Sep 2012 | US |